Angioedema

Urticaria and Angioedema

Volumn , Issue , 2010, Pages 117-127

  Borzova, Elena ^a   Grattan, Clive E H ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892317679     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-79048-8_14     Document Type: Chapter

References (54)

1. Lin RY, Cannon AG, Teitel AD. Pattern of hospitalizations for angioedema in New York between 1990 and 2003. Ann Allergy Asthma Immunol. 2005;95(2):159-66
2. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, Kapp A, Kozel MM, Maurer M, Merk HF, Schafer T, Simon D, Vena GA, Wedi B. EAACI/GA2LEN/EDF. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006;61(3):316-20
3. Grattan CE. The urticaria spectrum: recognition of clinical patterns can help management. Clin Exp Dermatol. 2004;29(3):217-21
4. Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol. 2003;28(2):123-7
5. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Hypersensitivity reactions to weak COX inhibitors. Allergy Clin Immunol Int. 2005;17:58-63
6. Woessner KM. Crossreacting drugs and chemicals. Clin Rev Allergy Immunol. 2003;24(2):149-158
7. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol. 2005;53(3):373-88
8. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145-53.
9. Erratum in: 2000;342(18):1376.
10. N Engl J Med 2000;342(10):748
11. Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens. 2004;17(2):103-11
12. Byrd JB, Adam A, Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am. 2006;26(4):725-37
13. Davis AE III. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am. 2006;26(4):633-51
14. Davis AE III. The pathophysiology of hereditary angioedema. Clin Immunol. 2005;114(1):3-9
15. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am. 2006;26(4):709-24
16. Zingale LC, Castelli R, Zanichelli A, Cicardi M. Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am. 2006;26(4):669-90
17. Banerji A, Weller PF, Sheikh J. Cytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome). Immunol Allergy Clin North Am. 2006;26(4):769-81
18. Klion AD, Bochner BS, Gleich GJ, Nutman TB, Rothenberg ME, Simon HU, Wechsler ME, Weller PF; The Hypereosinophilic Syndromes Working Group. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol. 2006;117(6):1292-302
19. Zingale LC, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi B, Cicardi M. Angioedema without urticaria: a large clinical survey. CMAJ. 2006;175(9):1065-70
20. Cicardi M, Bergamaschini L, Zingale LC, Gioffre D, Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med. 1999;106(6):650-4
21. Bracho FA Hereditary angioedema. Curr Opin Hematol. 2005;12(6):493-8
22. Koruth JS, Eckardt AJ, Levey JM. Hereditary angioedema involving the colon: endoscopic appearance and review of GI manifestations. Gastrointest Endosc. 2005;61(7):907-11
23. Marmery H, Mirvis SE. Angiotensin-converting enzyme inhibitor-induced visceral angioedema. Clin Radiol. 2006;61(11):979-82
24. Schmidt TD, McGrath KM. Angiotensin-converting enzyme inhibitor angioedema of the intestine: a case report and review of the literature. Am J Med Sci. 2002;324(2):106-8
25. Sarkar P, Nicholson G, Hall G. Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications. Can J Anaesth. 2006;53(10):994-1003
26. Fay A, Abinun M. Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency). J Clin Pathol. 2002;55(4):266-70
27. Williamson DW. Reticulate erythema - a prodrome in hereditary angio-oedema. Br J Derm 1979;1011:549-552
28. Gibbs JG, Craig TJ. Prodromal symptoms before exacerbations of hereditary angioedema. J Allergy Clin Immunol. 2007;119(1):S278
29. Zingale LC, Bork K, Farkas H, Bygum A, Bouillet L, Caballero T, Longhurst H, Waage Nielsen E, Bilo B, Bucher C, Perricone R, Cicardi M. The European register of hereditary angioedema: experience and preliminary results. J Allergy Clin Immunol 2007;119(1):S276
30. Morimoto T, Gandhi TK, Fiskio JM, Seger AC, So JW, Cook EF, Fukui T, Bates DW. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract. 2004;10(4):499-509
31. Abbosh J, Anderson JA, Levine AB, Kupin WL. Angiotensin converting enzyme inhibitorinduced angioedema more prevalent in transplant patients. Ann Allergy Asthma Immunol. 1999;82(5):473-6
32. Kemp SF, Lieberman P. Inhibitors of angiotensin ii: potential hazards for patients at risk for anaphylaxis? Ann Allergy Asthma Immunol. 1997;78(6):527-529
33. Kammerl MC, Schaefer RM, Schweda F, Schreiber M, Riegger GA, Kramer BK. Extracorporal therapy with AN69 membranes in combination with ACE inhibition causing severe anaphylactoid reactions: still a current problem? Clin Nephrol. 2000;53(6):486-8
34. Ebo DG, Bosmans JL, Couttenye MM, Stevens WJ. Haemodialysis-associated anaphylactic and anaphylactoid reactions. Allergy 2006;61:211-220
35. Weldon D. Differential diagnosis of angioedema. Immunol Allergy Clin North Am. 2006;26(4):603-13
36. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, Fay AC, Longhurst HJ, Morrison L, Price A, Price M, Watters D. C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139(3):379-94
37. Gompels MM, Lock RJ. Laboratory testing for C1 inhibitor deficiency: a comparison of two approaches to C1 inhibitor function. Ann Clin Biochem. 2007;44(Pt 1):75-8
38. Ricketti AJ, Cleri DJ, Ramos-Bonner LS, Vernaleo JR. Hereditary angioedema presenting in late middle age after angiotensin-converting enzyme inhibitor treatment. Ann Allergy Asthma Immunol. 2007;98(4):397-401
39. Longhurst HJ. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int J Clin Pract. 2005;59(5):594-9
40. Chiu AG, Newkirk KA, Davidson BJ, Burningham AR, Krowiak EJ, Deeb ZE. Angiotensinconverting enzyme inhibitor-induced angioedema: a multicenter review and an algorithm for airway management. Ann Otol Rhinol Laryngol. 2001;110(9):834-40
41. Oudit G, Girgrah N, Allard J. ACE inhibitor-induced angioedema of the intestine: case report, incidence, pathophysiology, diagnosis and management. Can J Gastroenterol. 2001;15(12):827-32
42. Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W, Zingale L, Varga L, Martinez-Saguer I, Aygoren-Pursun E, Binkley K, Zuraw B, Davis A III, Hebert J, Ritchie B, Burnham J, Castaldo A, Menendez A, Nagy I, Harmat G, Bucher C, Lacuesta G, Issekutz A, Warrington R, Yang W, Dean J, Kanani A, Stark D, McCusker C, Wagner E, Rivard GE, Leith E, Tsai E, MacSween M, Lyanga J, Serushago B, Leznoff A, Waserman S, De Serres J. Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol. 2004;114(3):629-37
43. Sica DA, Black HR. Current concepts of pharmacotherapy in hypertension: ACE inhibitorrelated angioedema: can angiotensin-receptor blockers be safely used? J Clin Hypertens (Greenwich). 2002;4(5):375-80
44. Orson FM. Intravenous immunoglobulin therapy suppresses manifestations of the angioedema with hypereosinophilia syndrome. Am J Med Sci. 2003;326(2):94-7
45. Sabroe RA, Glendinning AK, Sabroe I, Lawlor F, Kobza Black A. An audit of the use of self-administered adrenaline syringes in patients with angio-oedema. Br J Dermatol. 2002;146(4):615-20
46. Longhurst HJ, Carr S, Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option. Clin Exp Immunol. 2007;147(1):11-7
47. Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol. 2006;117(4):904-8
48. Blanch A, Roche O, Urrutia I, Gamboa P, Fontan G, Lopez-Trascasa M. First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol. 2006;118(6):1330-5
49. Sachse MM, Khachemoune A, Guldbakke KK, Kirschfink M. Hereditary angioedema. J Drugs Dermatol. 2006;5(9):848-52
50. Weiler CR, Van Dellen RG. Genetic test indications and interpretations in patients with hereditary angioedema. Mayo Clin Proc. 2006;81(7):958-72
51. Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006;343(4):1286-9
52. Nikpoor B, Duan QL, Rouleau GA. Acute adverse reactions associated with angiotensinconverting enzyme inhibitors: genetic factors and therapeutic implications. Expert Opin Pharmacother. 2005;6(11):1851-6
53. Zuraw BL. Novel therapies for hereditary angioedema. Immunol Allergy Clin North Am. 2006;26(4):691-708
54. Chinen J, Puck JM. Successes and risks of gene therapy in primary immunodeficiencies. J Allergy Clin Immunol. 2004;113(4):595-603